Terms: = Gastric cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
31 results:
1. Multi-dimension metabolic prognostic model for gastric cancer.
Feng W; Xu B; Zhu X
Front Endocrinol (Lausanne); 2023; 14():1228136. PubMed ID: 38144563
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
Liu Y; Zhang L; Lei X; Yin X; Liu S
Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
[TBL] [Abstract] [Full Text] [Related]
4. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract] [Full Text] [Related]
6. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer.
Jiang S; Ding X; Wu Q; Cheng T; Xu M; Huang J
Front Immunol; 2022; 13():980986. PubMed ID: 36032097
[TBL] [Abstract] [Full Text] [Related]
7. Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.
Xu C; Fang H; Gu Y; Yu K; Wang J; Lin C; Zhang H; Li H; He H; Liu H; Li R
Cancer Sci; 2022 Dec; 113(12):4070-4081. PubMed ID: 35997524
[TBL] [Abstract] [Full Text] [Related]
8. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract] [Full Text] [Related]
9. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in gastric cancer.
Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Characterization of RNA Processing Factors in gastric cancer Identifies a Prognostic Signature for Predicting clinical outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract] [Full Text] [Related]
11. Patterns of immune infiltration in gastric cancer and their clinical significance.
Jin Y; Tao L; Jin S; Cai W
Jpn J Clin Oncol; 2021 Jul; 51(7):1067-1079. PubMed ID: 33890063
[TBL] [Abstract] [Full Text] [Related]
12. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract] [Full Text] [Related]
13. ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of clinical outcome in Patients with gastric Carcinoma.
Wang T; Zhong H; Qin Y; Wei W; Li Z; Huang M; Luo X
Biomed Res Int; 2020; 2020():3575038. PubMed ID: 32685472
[TBL] [Abstract] [Full Text] [Related]
14. VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma.
Zhang L; Li L; Mao Y; Hua D
Sci Rep; 2020 Jan; 10(1):1355. PubMed ID: 31992826
[TBL] [Abstract] [Full Text] [Related]
15. A DNA methylation signature to improve survival prediction of gastric cancer.
Peng Y; Wu Q; Wang L; Wang H; Yin F
Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
[TBL] [Abstract] [Full Text] [Related]
16. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
[TBL] [Abstract] [Full Text] [Related]
17. Gut Microbiota Functional Biomolecules With Immune-Lipid Metabolism for a Prognostic Compound Score in Epstein-Barr Virus-Associated gastric Adenocarcinoma: A Pilot Study.
Wang F; Wu J; Wang Y; Jin Y; Jiang X; Qiu Z; Qin Y; Liu Y; Qi X; Ge X; Mao Y; Cheng Y; Hua D
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00074. PubMed ID: 31609743
[TBL] [Abstract] [Full Text] [Related]
18. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
Zhao H; Zhang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
[TBL] [Abstract] [Full Text] [Related]
19. The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer.
Liu F; Zhang S; Ren W; Yang T; Lv Y; Ling T; Zou X; Wang L
Surg Endosc; 2018 May; 32(5):2575-2582. PubMed ID: 29264757
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of short- and long-term outcomes of laparoscopic
Ye X; Kang WM; Yu JC; Ma ZQ; Xue ZG
World J Gastroenterol; 2017 Jul; 23(25):4595-4603. PubMed ID: 28740348
[TBL] [Abstract] [Full Text] [Related]
[Next]
